Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
Saegis Pharmaceuticals, Inc
Download detailed PDF Members: Saegis is a development-stage company focused on the discovery of drugs to address behavioral disorders. Saegis has clinically evaluated three small molecule drugs and has a growing pipeline of novel treatments for central nervous system (CNS) diseases involving cognitive dysfunction.The company's focus is on Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI), Cognitive Impairment Associated with Schizophrenia (CIAS), and Attention Deficit Hyperactivity Disorder (ADHD). By developing a new generation of CNS therapeutics, Saegis is committed to giving new hope to patients facing memory loss and cognition deficits associated with aging, psychiatric disorders and brain trauma.
This page has been viewed 894 times since April 2007, the link to the organisation's website has been followed 240 times Recent Search Terms used to find this page: Saegis Pharmaceutical website | saegis pharmaceuticals | Saegis Pharmaceuticals website | saegis pharmaceuticals | Saegis Pharmaceuticals | saegis pharmaceutics | Saegis Pharmaceuticals | Saegis Pharmaceuticals Inc. | Saegis Pharmaceuticals Inc. | Saegis Pharmaceuticals 2009 | . Search for more companies in Half Moon Bay Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Saegis Pharmaceuticals, Inc | |||||||||||||||||||||||||||||||||||||||||
|